US Stock MarketDetailed Quotes

PFC Premier Financial

Watchlist
  • 26.240
  • -0.050-0.19%
Trading Dec 26 13:33 ET
940.47MMarket Cap13.32P/E (TTM)

Premier Financial Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Premier Financial Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 66.200M--
--2024/Q4-- / 63.900M--
--2024/Q362.419M / 63.300M--
Jul 30, 20242024/Q261.551M / 63.100M--
Apr 23, 20242024/Q162.145M / 63.270M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 66.200M--
--2024/Q4-- / 63.900M--
--2024/Q362.419M / 63.300M--
Jul 30, 20242024/Q261.551M / 63.100M--
Apr 23, 20242024/Q162.145M / 63.270M--

Unlock Free Earnings Estimates

Premier Financial Earnings Reports

  • Premier Financial | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:12 ET

  • Premier Financial | 8-K: PREMIER FINANCIAL CORP. ANNOUNCES THIRD QUARTER 2024 RESULTS Declared dividend of $0.31 per share

    Oct 22 16:24 ET

  • Premier Financial | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:16 ET

  • Premier Financial | 10-Q: Q1 2024 Earnings Report

    May 2 11:33 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    SilverCrest Metals
    SILV
    +1.36%
    Collegium Pharmaceutical
    COLL
    +1.17%
    Cars.com
    CARS
    +0.95%
    Hutchmed (China)
    HCM
    +0.87%
    Halozyme Therapeutics
    HALO
    +0.69%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Nov 1, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data